Salman Ahmadian
Overview
Explore the profile of Salman Ahmadian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kargar S, Dalimi A, Eslami G, Hajimohammadi B, Shirinzadeh A, Amouei A, et al.
Surg Infect (Larchmt)
. 2022 May;
23(5):451-457.
PMID: 35527685
Cystic echinococcosis (CE) is caused by . In Central Iran, no molecular information is available on CE in humans. Therefore, in this study, we identified the genotyping of hydatid cysts...
2.
Hajimohammadi B, Ahmadian S, Firoozi Z, Askari M, Mohammadi M, Eslami G, et al.
Ecohealth
. 2022 Feb;
19(1):55-74.
PMID: 35133541
Toxoplasma gondii causes toxoplasmosis with a global prevalence in the world. A large proportion of human illness is most frequently associated with consuming raw and undercooked meat or other animal...
3.
Hajimohammadi B, Dalimi A, Eslami G, Ahmadian S, Zandi S, Baghbani A, et al.
BMC Vet Res
. 2022 Jan;
18(1):22.
PMID: 34996460
Background: The species complex of Echinococcus granulosus sensu lato (s.l.) causes cystic echinococcosis distributed worldwide. There is no genotype information from hydatid cysts in the intermediate hosts in Central Iran....
4.
Hajimohammadi B, Eslami G, Zandi H, Ehrampoush M, Naimi A, Derakhshan M, et al.
Sci Rep
. 2021 Jan;
11(1):1126.
PMID: 33441963
Rice is considered one of the most important staple food crops. Genetically modified (GM) Bt rice, harbored cry1Ab gene expressing the insect-resistance protein has been developed to resistance to the...
5.
Abtahi M, Eslami G, Cavallero S, Vakili M, Hosseini S, Ahmadian S, et al.
BMC Res Notes
. 2020 Mar;
13(1):126.
PMID: 32178715
Objective: Leishmaniasis is caused by different Leishmania spp. Treatment failure (TF) of cutaneous leishmaniasis (CL) is a serious issue that may be due to various reasons, previous studies suggested Leishmania...
6.
Alijani Y, Hosseini S, Ahmadian S, Boughattas S, Eslami G, Naderian S, et al.
J Arthropod Borne Dis
. 2019 Dec;
13(2):145-152.
PMID: 31803775
Background: Regarding the antimonial-resistant of spp., understanding of related mechanism is necessary. One of the most important involved molecules is aquaglyceropin1 (AQP1). The aim of this study was molecular analysis...
7.
Eslami G, Ghavami M, Moradi A, Nadri H, Ahmadian S
Iran J Parasitol
. 2019 Nov;
14(3):465-471.
PMID: 31673266
Background: The first line treatment for cutaneous leishmaniasis is pentavalent antimony such as sodium stibogluconate (pentostam) and meglumine antimonite (glucantime). One of the most important ways to uptake the drug...
8.
Ahmadian S, Eslami G, Fatahi A, Hosseini S, Vakili M, Ajamein Fahadan V, et al.
J Parasit Dis
. 2019 Apr;
43(1):39-45.
PMID: 30956444
Cutaneous leishmaniasis (CL) is a major disease in many parts of the world. Since no vaccine has been developed, treatment is the best way to control it. In most areas,...
9.
Ajamein V, Eslami G, Ahmadian S, Khamesipour A, Elloumi M
Ann Parasitol
. 2018 Oct;
64(3):181-187.
PMID: 30316208
Cutaneous leishmaniosis (CL) is treated with pentavalent antimony (SbV) as a first-line drug, while amphotericin B and paromomycin are potential alternatives in antimonial- resistant isolates. However, the mechanisms of drug...